An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models
Authors:
Open Access
- 1 July 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (7) , 1316-1322
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Antisense-mediated exon skipping: A versatile tool with therapeutic and research applicationsRNA, 2007
- The versatility of oligonucleotides as potential therapeuticsExpert Opinion on Biological Therapy, 2007
- Modulating the Expression of Disease Genes with RNA-Based TherapyPLOS Genetics, 2007
- Collagen-induced arthritisNature Protocols, 2007
- Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animalsNucleic Acids Research, 2006
- Analysis of Prostate-Specific Membrane Antigen Splice Variants in LNCap CellsOligonucleotides, 2006
- Tumor Necrosis Factor-induced Toxic Liver Injury Results from JNK2-dependent Activation of Caspase-8 and the Mitochondrial Death PathwayJournal of Biological Chemistry, 2006
- Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathologyNature Medicine, 2006
- Current managementActa Orthopaedica, 2005
- Anti-TNF-α therapies: the next generationNature Reviews Drug Discovery, 2003